| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.26B | -2.7% |
| R&D Expense | $21.8M | +4.3% |
| SG&A Expense | $221.1M | +16.8% |
| Operating Income | -$1.98B | -198.8% |
| Pre-tax Income | -$2.70B | -218.1% |
| Income Tax | -$12.7M | -654.0% |
| Net Income | -$1.60B | -1025.4% |
| EPS (Basic) | -$7.41 | -1003.7% |
| EPS (Diluted) | -$7.41 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $172.0M | -19.7% |
| Inventory | $459.7M | -41.4% |
| Current Assets | $1.88B | -10.3% |
| Total Assets | $20.45B | +6.1% |
| Current Liabilities | $1.49B | +28.8% |
| Long-term Debt | $10.67B | +27.1% |
| Total Liabilities | $13.54B | +22.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$820.7M | +3.3% |
| Capital Expenditures | $21.0M | +15.1% |
| Investing Cash Flow | -$2.61B | -25.3% |
| Financing Cash Flow | $3.47B | +14.2% |
| Free Cash Flow | -$841.7M | +2.9% |
| -1026.3% |
| Stockholders' Equity |
| $5.23B |
| -22.0% |